A Canadian pharmaceuticals/consumer products company approached Freyr for the creation of Annual Summary Reports (CASR) for four (4) products. Due to shortage of Regulatory information from the client in relation to previously submitted sequences, Freyr team had to import and validate sequences produced and submitted by another vendor. Furthermore, there were no Regulatory strategies in place to decipher the requirements for different regions to process the submissions.

Learn how Freyr overcame the obstacles and provided Regulatory services to create annual summary reports as per the Health Canada guidelines. Download the proven case.